Page 2 - Alfredo Perales Puchalt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alfredo perales puchalt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alfredo Perales Puchalt Today - Breaking & Trending Today

Anixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology

— Technology currently being evaluated for the treatment of ovarian cancer in Phase 1 clinical trial —
SAN JOSE, Calif., July 11, 2023 /PRNewswire/ Anixa Biosciences, Inc. , a. ....

Amit Kumar , Mike Catelani , Alfredo Perales Puchalt , Stephen Kilmer , Jose Conejo Garcia , Wistar Institute , Anixa Biosciences Inc , Canadian Intellectual Property Office , Prnewswire Anixa Biosciences Inc , Certainty Therapeutics Inc , Moffitt Cancer Center , Canadian Patent , Chimeric Antigen Receptor T , Moffitt Cancer , Treating Cancer , Certainty Therapeutics , Follicle Stimulating Hormone Receptor Mediated , Anixa Biosciences , Cleveland Clinic , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy

/PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious. ....

Eric Ribner , Jose Conejo Garcia , Anixa Biosciences , Alfredo Perales Puchalt , Amit Kumar , Mike Catelani , Anixa Bioscience , Lifesci Advisors , Drug Administration , Moffitt Cancer Center , Prnewswire Anixa Biosciences Inc , Trademark Office , Anixa Biosciences Inc , Department Of Immunology At Moffitt Cancer Center , Certainty Therapeutics Inc , Wistar Institute , Chimeric Antigen Receptor T , Chimeric Endocrine Receptort Cell , Stimulating Hormone Receptor Mediated , Moffitt Cancer , Treating Cancer , Vice President , Certainty Therapeutics , Follicle Stimulating Hormone Receptor Mediated , Stimulating Hormone Receptor , Looking Statements ,

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

United States , Jose Conejo Garcia , Heathera Steinman , Anixa Biosciences , Alfredo Perales Puchalt , Amit Kumar , Mike Catelani , Anixa Bioscience , European Patent Office , Moffitt Cancer Center , Anixa Biosciences Inc , Department Of Immunology At Moffitt Cancer Center , European Union , Certainty Therapeutics Inc , Wistar Institute , Business Development , Vice President , Certainty Therapeutics , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , European Patent , Ovarian Cancer , Biotechnology Company ,

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Jose Conejo Garcia , Heathera Steinman , Anixa Biosciences , Alfredo Perales Puchalt , Amit Kumar , Mike Catelani , Anixa Bioscience , European Patent Office , Moffitt Cancer Center , Anixa Biosciences Inc , Department Of Immunology At Moffitt Cancer Center , European Union , Certainty Therapeutics Inc , Wistar Institute , Business Development , Moffitt Cancer , Vice President , Certainty Therapeutics , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , ஒன்றுபட்டது மாநிலங்களில் , ஜோசே கோனேஜு கார்சியா ,

Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs

Geneos Therapeutics Secures $12 Million in Series A1 Financing to Advance Personalized Cancer Immunotherapy Programs
Geneos expands its lead program for treating patients with advanced hepatocellular carcinoma
Geneos adds to its leadership team
News provided by
Share this article
Share this article
PLYMOUTH MEETING, Pa., March 3, 2021 /PRNewswire/ Geneos Therapeutics, a clinical stage company focused on the development of tumor neoantigen targeted personalized immunotherapies for cancer, announced today that it has closed its Series A1 round, raising $12 million in financing. The financing was led by Korea Investment Partners (KIP) – Global Bio Fund with strong participation from all existing Series A investors including, notably, Santé Ventures and Inovio Pharmaceuticals, Inc. (NASDAQ: INO). The new investment follows the previously announced initial financing of $10.5 million in February 2019. In conjunction with the financing, Mr. Sangwoo Lee, Manag ....

United States , South Korea , Hakim Hammach , Sangwoo Lee , Alfredo Perales Puchalt , Niranjany Sardesai , United States Inc , Global Bio Fund , Inovio Pharmaceuticals , Inovio Pharmaceuticals Inc , Research Development , Business Development , Korea Investment Partners , Managing Director Korea Investment Partners , Geneo Board , Chief Executive Officer , Joann Peters , Vice President , Business Operations , Federicao Brien , Strategic Finance , Geneos Therapeutics , Neoantigen Targeting Platform , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , சாங்குவூ லீ ,